NASDAQ:NXL

Nexalin Technology (NXL) Stock Price, News & Analysis

Nexalin Technology logo
$1.44 -0.06 (-4.00%)
Closing price 11/18/2026 03:58 PM Eastern
Extended Trading
$1.51 +0.07 (+4.86%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Nexalin Technology Stock (NASDAQ:NXL)

Advanced

Key Stats

Today's Range
$1.41
▼
$1.50
50-Day Range
$1.40
▼
$7.55
52-Week Range
$1.31
▼
$33.60
Volume
14,506 shs
Average Volume
28,301 shs
Market Capitalization
$1.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Nexalin Technology develops non-invasive neurostimulation devices for behavioral health applications. Its technology delivers low-level electrical signals through electrodes placed on the head, with the aim of supporting care for conditions such as anxiety, depression and insomnia.

The company’s product line includes its Gen-2 and Gen-3 cranial electrotherapy stimulation devices. Nexalin focuses on developing and commercializing these systems for use by healthcare providers and patients, and has pursued regulatory clearances and distribution opportunities in the United States and international markets.

AI Generated. May Contain Errors.

Nexalin Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

NXL MarketRank™: 
0.538377343 of 5 stars

Nexalin Technology scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nexalin Technology has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Nexalin Technology has only been the subject of 2 research reports in the past 90 days.

  • Read more about Nexalin Technology's stock forecast and price target.
  • Earnings Growth

    Earnings for Nexalin Technology are expected to grow in the coming year, from ($11.42) to ($7.55) per share.

  • Price to Book Value per Share Ratio

    Nexalin Technology has a P/B Ratio of 4.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.06% of the float of Nexalin Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Nexalin Technology has a short interest ratio ("days to cover") of 0.21, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nexalin Technology has recently increased by 180.70%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nexalin Technology does not currently pay a dividend.

  • Dividend Growth

    Nexalin Technology does not have a long track record of dividend growth.

  • News Sentiment

    Nexalin Technology has a news sentiment score of -1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Nexalin Technology this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Nexalin Technology to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nexalin Technology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.09% of the stock of Nexalin Technology is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    0.65% of the stock of Nexalin Technology is held by institutions.

  • Read more about Nexalin Technology's insider trading history.
Receive NXL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NXL Stock News Headlines

Your $7 scanner is waiting
The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
NXL - Nexalin Technology, Inc.
See More Headlines

NXL Stock Analysis - Frequently Asked Questions

Nexalin Technology's stock was trading at $16.74 on January 1st, 2026. Since then, NXL stock has decreased by 91.4% and is now trading at $1.44.

Nexalin Technology, Inc. (NASDAQ:NXL) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($3.43) EPS for the quarter, missing analysts' consensus estimates of ($2.91) by $0.52. The business had revenue of $78.30 thousand for the quarter, compared to the consensus estimate of $75 thousand. Nexalin Technology had a negative net margin of 3,384.12% and a negative trailing twelve-month return on equity of 445.53%.

Nexalin Technology's stock reverse split before market open on Monday, August 31st 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, August 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Nexalin Technology (NXL) raised $14 million in an IPO on Friday, September 16th 2022. The company issued 2,315,000 shares at a price of $5.00-$7.00 per share.

Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nexalin Technology investors own include Intel (INTC), SoundHound AI (SOUN), IonQ (IONQ), UiPath (PATH), Micron Technology (MU), NVIDIA (NVDA) and Palantir Technologies (PLTR).

Company Calendar

Last Earnings
11/12/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:NXL
CIK
1527352
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($13.94)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.22 million
Net Margins
-3,384.12%
Pretax Margin
-3,384.48%
Return on Equity
-445.53%
Return on Assets
-256.45%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.69
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$300 thousand
Price / Sales
3.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.36 per share
Price / Book
4.00

Miscellaneous

Outstanding Shares
730,000
Free Float
609,000
Market Cap
$1.05 million
Optionable
Not Optionable
Beta
4.31
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:NXL) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners